COVID-19 treatment | Natco Pharma seeks approval to launch phase-3 trial of Molnupiravir

COVID-19 treatment | Natco Pharma seeks approval to launch phase-3 trial of Molnupiravir Natco said it is hoping that CDSCO would give emergency approval of this drug based on “compassionate use” for patients.

from Moneycontrol Business News https://www.moneycontrol.com/news/business/covid-19-treatment-|-natco-pharma-seeks-approval-to-launch-phase-3-trialmolnupiravir_15035401.html
Posted by: at
Tags:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Start-up Street: Social justice and the start-up ecosystem

Disparities in start-ups are a global phenomenon and affirmative action is needed to ensure an equal opportunities environment for aspiring...